Gadobutrol

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 65219-287
  • Package NDC 65219-287-30
  • Application number ANDA216081
  • SPL ID d546f4fe-ebb3-47cf-9222-563d15caa8b1
  • SPL set ID c0dd1618-0bb3-4974-846b-e5afc2311ae6
  • UNII 1BJ477IO2L

What the source publishes

Labeler
Fresenius Kabi USA, LLC
Active ingredients
Gadobutrol
Form
INJECTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:65219-287_d546f4fe-ebb3-47cf-9222-563d15caa8b1
{
  "name": "Gadobutrol",
  "splId": "d546f4fe-ebb3-47cf-9222-563d15caa8b1",
  "labels": [
    {
      "setId": "c0dd1618-0bb3-4974-846b-e5afc2311ae6",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0dd1618-0bb3-4974-846b-e5afc2311ae6",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c0dd1618-0bb3-4974-846b-e5afc2311ae6"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "Fresenius Kabi USA, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "10 BOTTLE in 1 CARTON (65219-287-30)  / 30 mL in 1 BOTTLE (65219-287-10)",
      "package_ndc": "65219-287-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20231001"
    }
  ],
  "productId": "65219-287_d546f4fe-ebb3-47cf-9222-563d15caa8b1",
  "useDomain": "unknown",
  "dosageForm": "INJECTION",
  "productNdc": "65219-287",
  "deaSchedule": null,
  "genericName": "Gadobutrol",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "GADOBUTROL",
      "strength": "604.72 mg/mL"
    }
  ],
  "applicationNumber": "ANDA216081",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20231001",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000183362",
      "N0000175862"
    ],
    "unii": [
      "1BJ477IO2L"
    ],
    "spl_set_id": [
      "c0dd1618-0bb3-4974-846b-e5afc2311ae6"
    ],
    "pharm_class_epc": [
      "Gadolinium-based Contrast Agent [EPC]"
    ],
    "pharm_class_moa": [
      "Magnetic Resonance Contrast Activity [MoA]"
    ],
    "manufacturer_name": [
      "Fresenius Kabi USA, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:65219-287_d546f4fe-ebb3-47cf-9222-563d15caa8b1"